1993
DOI: 10.1203/00006450-199302000-00011
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of Insulin-Like Growth Factor Binding Protein-3 in Chronic Renal Failure Serum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
32
1

Year Published

1995
1995
2004
2004

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 64 publications
(36 citation statements)
references
References 40 publications
3
32
1
Order By: Relevance
“…Similar comparisons for groups of subjects with GH disorders (all GH-deficient subjects, all acromegalic subjects) are shown in Table 3; again, correlation coefficients were high (in the range 0·82-0·98), and the slopes of regression lines for comparisons of Method 4 vs Method 1 were consistently lower than for comparisons between Methods 2 or 3 vs Method 1, consistent with a systematic effect of assay calibration for Method 4. The final comparisons were for samples from pregnant subjects and patients with chronic renal failure, both conditions where proteolysis of IGFBP-3 is reported to occur (Hossenlopp et al 1990, Powell et al 1993. In these relatively small sample groups, greater discrepancies among some of the methods were seen than in the other patient groups (Table 3).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Similar comparisons for groups of subjects with GH disorders (all GH-deficient subjects, all acromegalic subjects) are shown in Table 3; again, correlation coefficients were high (in the range 0·82-0·98), and the slopes of regression lines for comparisons of Method 4 vs Method 1 were consistently lower than for comparisons between Methods 2 or 3 vs Method 1, consistent with a systematic effect of assay calibration for Method 4. The final comparisons were for samples from pregnant subjects and patients with chronic renal failure, both conditions where proteolysis of IGFBP-3 is reported to occur (Hossenlopp et al 1990, Powell et al 1993. In these relatively small sample groups, greater discrepancies among some of the methods were seen than in the other patient groups (Table 3).…”
Section: Resultsmentioning
confidence: 99%
“…The functional abnormality in pregnancy IGFBP-3 is thus still controversial. In contrast, the proteolyzed form of IGFBP-3 seen in renal failure serum has an obvious functional abnormality since it circulates at a low molecular weight and fails to complex with ALS (Powell et al 1993 .…”
Section: Nsmentioning
confidence: 99%
“…The circulating half-lives of IGF-I and IGF-II are reported to be about 10 min in the free form, less than 30 min in binary complexes, and 12-15 h in the ternary complexed form (6). IGFBP-3 has been extensively documented as being unique among the IGFBPs in its ability to form ternary complexes with the IGFs and ALS (4,(7)(8)(9)(10). These complexes are thus thought to form a circulating reservoir of IGFBP-3 and IGFs because, unlike free and binary complexed IGFs, they appear unable to undergo transcapillary passage to tissues and have a long circulating half-life, predominantly due to the stabilizing effect of ALS (11,12).…”
mentioning
confidence: 99%
“…IGFBP-3 may accumulate in circulation in renal failure, due to decreased renal excretion [18,19]. IGF-I may be much more bound to IGFBP-3 under such condition as an increase in IGFBP-3 and that may result in a reduced free IGF-I level, which may cause growth retardation [1,10,20,21].…”
Section: Discussionmentioning
confidence: 99%
“…Thus it is necessary to investigate those values in the uremic children estimating by immunoblotting assay, cross-linking assay, RIA or chromatography methods of IGFBPs [18].…”
Section: Discussionmentioning
confidence: 99%